SABTX Performance — SA U.S. Value Fund
Data updated: 2026-09-03
SABTX returned +18.75% year to date and +33.23% over one year to Jun 2026. Annualised returns are +18.81% over 3 years and +11.45% over 5 years. The fund beat its US Large Value category average: $100 invested three years ago grew to $168, against $158 for the category, and to $133 over one year, against $121. Volatility over the past three years was 13.18% a year. In the 12 months to Jun 2026 the fund lost a net $32.9M, and assets reached $636.21M.
SABTX Growth of $100
What $100 invested in SA U.S. Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | SABTX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $133 | $121 |
| 3 years (Jul 2023 – Jun 2026) | $168 | $158 |
| 5 years (Jul 2021 – Jun 2026) | $172 | $165 |
| Since data start (Jul 2019 – Jun 2026) | $222 | $223 |
SABTX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +18.75% |
| 1 year | +33.23% |
| 3 years (annualised) | +18.81% |
| 5 years (annualised) | +11.45% |
SABTX Annual Returns
Calendar-year total returns of SA U.S. Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +18.75% |
| 2025 | +17.67% |
| 2024 | +11.37% |
| 2023 | +11.81% |
| 2022 | −6.38% |
| 2021 | +26.98% |
| 2020 | −2.02% |
| 2019 (Jul–Dec) | +9.61% |
SABTX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.0% | +3.4% | −4.0% | +6.9% | +4.2% | +2.3% | — | — | — | — | — | — |
| 2025 | +4.5% | +1.0% | −2.4% | −5.0% | +2.3% | +4.7% | +0.5% | +5.1% | +1.4% | −0.2% | +2.8% | +2.1% |
| 2024 | +0.7% | +3.6% | +6.6% | −4.7% | +2.8% | −1.1% | +4.8% | +1.1% | +0.4% | −0.7% | +6.3% | −7.9% |
| 2023 | +6.0% | −3.5% | −1.6% | +1.2% | −4.8% | +6.9% | +4.4% | −2.7% | −2.6% | −3.8% | +7.1% | +5.8% |
| 2022 | −1.6% | −0.5% | +1.8% | −5.9% | +4.2% | −10.7% | +6.1% | −2.8% | −8.6% | +12.7% | +5.9% | −4.5% |
| 2021 | +0.2% | +7.7% | +6.1% | +3.8% | +3.3% | −2.0% | −0.2% | +2.1% | −3.4% | +4.0% | −2.7% | +6.0% |
| 2020 | −4.3% | −10.6% | −20.3% | +12.8% | +3.7% | −1.1% | +3.0% | +4.3% | −2.5% | −1.4% | +15.8% | +3.6% |
| 2019 | — | — | — | — | — | — | +1.1% | −4.2% | +3.9% | +2.1% | +3.9% | +2.7% |
SABTX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.18%
- 3-year Sharpe ratio: 1.09 (vs 4.5% risk-free rate)
- Best month: +7.13% (Nov 2023)
- Worst month: −7.86% (Dec 2024)
SABTX Fund Flows
Monthly money in and out of SA U.S. Value Fund, from SEC Form N-PORT.
- 12-month net flow: −$32.9M
- 12-month gross sales (incl. reinvestments): $114.7M
- Sales ÷ redemptions: 0.78×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $15.5M | $24.6M | −$9.1M |
| May 2026 | $6.6M | $13.1M | −$6.5M |
| Apr 2026 | $7.5M | $13.0M | −$5.5M |
| Mar 2026 | $8.2M | $11.7M | −$3.6M |
| Feb 2026 | $7.8M | $11.1M | −$3.3M |
| Jan 2026 | $8.2M | $14.2M | −$5.9M |
| Dec 2025 | $31.4M | $17.9M | $13.5M |
| Nov 2025 | $5.4M | $8.7M | −$3.3M |
| Oct 2025 | $8.0M | $11.8M | −$3.7M |
| Sep 2025 | $4.9M | $7.5M | −$2.7M |
| Aug 2025 | $5.8M | $7.2M | −$1.4M |
| Jul 2025 | $5.5M | $6.9M | −$1.4M |
SABTX Assets Under Management
Net assets of SA U.S. Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $636.21M |
| 2026-03-31 | $578.12M |
| 2025-12-31 | $566.63M |
| 2025-09-30 | $555.44M |
| 2025-06-30 | $523.78M |
| 2025-03-31 | $539.71M |
| 2024-12-31 | $537.70M |
| 2024-09-30 | $569.66M |
| 2024-06-30 | $546.59M |
| 2024-03-31 | $582.22M |
| 2023-12-31 | $538.16M |
| 2023-09-30 | $505.32M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.